260 related articles for article (PubMed ID: 21768666)
1. Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India.
Pasricha S; Gupta A; Gawande J; Trivedi P; Patel D
Indian J Cancer; 2011; 48(2):199-203. PubMed ID: 21768666
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003).
Sarkar C; Sharma MC; Deb P; Singh R; Santosh V; Shankar SK
J Neurooncol; 2005 Jan; 71(2):199-204. PubMed ID: 15690139
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
4. A study of primary central nervous system lymphoma in northern India.
Powari M; Radotra B; Das A; Banerjee AK
Surg Neurol; 2002 Feb; 57(2):113-6. PubMed ID: 11904205
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma: patterns of incidence in Indian population and effect of steroids on stereotactic biopsy yield.
Manoj N; Arivazhagan A; Mahadevan A; Bhat DI; Arvinda HR; Devi BI; Sampath S; Chandramouli BA
Neurol India; 2014; 62(1):19-25. PubMed ID: 24608449
[TBL] [Abstract][Full Text] [Related]
6. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
8. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma.
Chen BB; Xu XP; Shen L; Han TJ; Lin ZG; Chen Z; Kang H; Huang B; Lin GW
Chin Med J (Engl); 2013 Feb; 126(3):482-7. PubMed ID: 23422111
[TBL] [Abstract][Full Text] [Related]
10. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
11. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of c-Myc in primary central nervous system lymphoma of Thais.
Assanasen T; Shuangshoti S; Nilyai S; Wannakrairot P; Ruangvejvorachai P; Sawatdee R; Sangprakarn S
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S40-6. PubMed ID: 17718267
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphomas: a 30-year experience at a single institution.
Nuckols JD; Liu K; Burchette JL; McLendon RE; Traweek ST
Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
[TBL] [Abstract][Full Text] [Related]
14. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma.
Gerstner ER; Batchelor TT
Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
[TBL] [Abstract][Full Text] [Related]
16. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
17. Decreasing incidence rates of primary central nervous system lymphoma.
Kadan-Lottick NS; Skluzacek MC; Gurney JG
Cancer; 2002 Jul; 95(1):193-202. PubMed ID: 12115333
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of primary central nervous system lymphoma.
Moradi A; Tajedini A; Mehrabian A; Sadeghi S; Semnani V; Khodabakhshi R; Arefian N; Afrakhteh M; Keshvari K; Yavari P; Madani-Civi M
Neurosciences (Riyadh); 2006 Oct; 11(4):284-8. PubMed ID: 22266438
[TBL] [Abstract][Full Text] [Related]
19. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
20. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
